Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Mhealth ; 7: 57, 2021.
Article in English | MEDLINE | ID: covidwho-2295125

ABSTRACT

BACKGROUND: Academic-industry collaborations (AICs) are endorsed to alleviate challenges in digital health, but partnership experiences remain understudied. The qualitative study's objective investigated collaboration experiences between academic institutions and digital health companies. METHODS: A phenomenology methodology captured experiences of AICs, eliciting perspectives from academic researchers and industry affiliates (e.g., leadership, company investigators). Semi-structured interviews probed eligible collaborators about their experiences in digital health. Analysts coded and organized data into significant statements reaching thematic saturation. RESULTS: Participants (N=20) were interviewed from 6 academic institutions and 14 unique industry partners. Seven themes emerged: (I) Collaboration evolves with time, relationships, funding, and evidence; (II) Collaboration demands strong relationships and interpersonal dynamics; (III) Operational processes vary across collaborations; (IV) Collaboration climate and context matters; (V) Shared expectations lead to a better understanding of success; (VI) Overcoming challenges with recommendations; (VII) Collaboration may help navigate the global pandemic. CONCLUSIONS: Digital health academic industry collaboration demands strong relationships, requiring flexible mechanisms of collaboration and cultural fit. Diverse models of collaboration exist and remain dependent on contextual factors. While no collaboration conquers all challenges in digital health, AICs may serve as a facilitator for improved digital health products, thus advancing science, promoting public health, and benefiting the economy.

2.
Int J Behav Nutr Phys Act ; 19(1): 157, 2022 12 22.
Article in English | MEDLINE | ID: covidwho-2196332

ABSTRACT

BACKGROUND: Partnering with a public transport (PT) provider, state government, and local government, the single-blinded randomised controlled trial, trips4health, investigated the impact of PT use incentives on transport-related physical activity (PA) in Tasmania, Australia. The intervention involved 16-weeks of incentives (bus trip credits) for achieving weekly PT use targets, supported by weekly text messages. This study objective was to conduct a process evaluation of the COVID-19 disrupted trips4health study. METHODS: The Medical Research Council UK's framework for complex public health interventions guided the process evaluation. Participant reach, acceptability, fidelity and feasibility were evaluated. Administrative and post-intervention survey data were analysed descriptively. Semi-structured interviews with intervention participants (n = 7) and PT provider staff (n = 4) were analysed thematically. RESULTS: Due to COVID-19, trips4health was placed on hold (March 2020) then stopped (May 2020) as social restrictions impacted PT use. At study cessation, 116 participants (approximately one third of target sample) had completed baseline measures, 110 were randomised, and 64 (n = 29 in the intervention group; n = 35 in the control group) completed post-intervention measures. Participants were 18 - 80 years (average 44.5 years) with females (69%) and those with tertiary education (55%) over-represented. The intervention was delivered with high fidelity with 96% of bus trip credits and 99% of behavioural text messages sent as intended. Interviewed PT staff said implementation was highly feasible. Intervention participant acceptability was high with 90% reporting bus trip incentives were helpful and 59% reporting the incentives motivated them to use PT more. From a total of 666 possible bus trip targets, 56% were met with 38% of intervention participants agreeing and 41% disagreeing that 'Meeting the bus trip targets was easy'. Interviews and open-ended survey responses from intervention participants revealed incentives motivated bus use but social (e.g., household member commitments) and systemic (e.g., bus availability) factors made meeting bus trip targets challenging. CONCLUSIONS: trips4health demonstrated good acceptability and strong fidelity and feasibility. Future intervention studies incentivising PT use will need to ensure a broader demographic is reached and include more supports to meet PT targets. TRIAL REGISTRATION: ACTRN12619001136190 .


Subject(s)
COVID-19 , Female , Humans , COVID-19/prevention & control , Motivation , Exercise , Health Behavior , Surveys and Questionnaires
3.
Texila International Journal of Public Health ; 9(2), 2021.
Article in English | CAB Abstracts | ID: covidwho-1876345

ABSTRACT

The coronavirus global pandemic now poses additional peril to the already burdened healthcare systems with inadequate funding in Africa. This paper attempts to present the funding patterns for healthcare in Nigeria, Congo, Tanzania, Egypt, and South Africa. It also explored investor opportunities for lowering OOPs and increasing investor profits. Data were drawn from the WHO, the World Bank, and world charts databases. Government health expenditure was far below what individuals and families pay from out-of-pocket payments (OOPs) for healthcare services except in South Africa, where OOP accounts for only 8%. Contrary to popular notion, donation funds or foreign aid for healthcare accounts for a lower percentage of total healthcare expenditure in the countries under consideration. Households mostly bore the healthcare expenditure burden (Nigeria's OOPs of 77%, Congo- 48%, and Egypt- 60%). Averagely, Nigeria and Congo only spent about 3% of their national budget on healthcare. In comparison, Tanzania and Egypt spent an average of 4% and 5% (South Africa-8%) between 2010 and 2017, reflecting low-risk protection for households. Specific aspects for investments through public-private partnerships (PPP) reviewed in this paper should include designing innovative financing models focusing on risk pooling mechanisms to help bridge the funding gap, local production, and manufacture of pharmaceuticals and healthcare equipment at this time, instead of importation. Investors can, therefore, take advantage of the various initiatives outlined in this paper to achieve better health outcomes in Africa.

5.
Yonsei Med J ; 62(9): 777-791, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-1370980

ABSTRACT

The government of the Republic of Korea (ROK) has established relevant laws and a master plan for infectious disease control and prevention based on their experiences with past epidemics. In addition, the Ministry of Health and Welfare has designed a standard manual for risk management that involves pan-governmental crisis management systems. This national infectious disease management system is constantly being supplemented and developed in face of infectious disease-related crises. In this study, we set out to present directions for infectious disease prevention and flow of management and governance between central and local governments to ensure systematic quarantine activities in the ROK. During the coronavirus disease 2019 (COVID-19) pandemic, public-private partnerships have been established to collect, provide, process, and disseminate information for effective quarantine. This has enabled the development and rapid approval of test kits, the tracking of cases, and the allocation of appropriate resources for patient treatment. Additionally, the Infectious Disease Control Agency has actively utilized information and communication technology platforms to disclose information necessary in real-time for COVID-19 quarantine and management. Overall, these efforts have played an important role in epidemiological investigations, patient management, and quarantine in the early stages of the COVID-19 pandemic.


Subject(s)
COVID-19 , Pandemics , Humans , Pandemics/prevention & control , Public-Private Sector Partnerships , Republic of Korea/epidemiology , SARS-CoV-2
6.
Int J Environ Res Public Health ; 18(11)2021 06 07.
Article in English | MEDLINE | ID: covidwho-1266742

ABSTRACT

Public-private partnerships (PPP) represent an alternative model of health management focused on improving the quality of health services, particularly in emerging countries. To date, a systematic method to improve the perceived quality of health services by healthcare users in Peru has not been established. The purpose of this study was to evaluate the quality of health services in two PPP hospitals in Peru using the Kano model. A prospective cross-sectional descriptive observational study was carried out through a health service satisfaction survey using the Kano model methodology, measuring six categories of attributes. A total of 250 users of the health services were surveyed in the two PPP hospitals, located in Lima and Callao, using non-probability convenience sampling. Of the 31 attributes evaluated by the patients, 27 (81%) were classified as having a one-dimensional-type attribute, 3 (10%) were reported as mandatory, and 1 (3%) was considered as inverse. These results suggest that the presence of most of the attributes evaluated was relevant to maintaining the level of user satisfaction and that the absence of these attributes generated dissatisfaction in the users. The results showed that the users' evaluation of health services was multidimensional-namely, their evaluation was focused not only on the interaction space between the patient and medical personnel but also addressed other interaction services.


Subject(s)
Health Services , Patient Satisfaction , Cross-Sectional Studies , Humans , Nigeria , Peru , Prospective Studies , Quality of Health Care
7.
Front Public Health ; 8: 571419, 2020.
Article in English | MEDLINE | ID: covidwho-921174

ABSTRACT

Background: The private medical sector is a resource that must be estimated for efficient inclusion into public healthcare during pandemics. Methods: A survey was conducted among private healthcare workers to ascertain their views on the potential resources that can be accessed from the private sector and methods to do the same. Results: There were 213 respondents, 80% of them being doctors. Nearly half (47.4%) felt that the contribution from the private medical sector has been suboptimal. Areas suggested for improved contributions by the private sector related to patient care (71.8%) and provision of equipment (62.4%), with fewer expectations (39.9%) on the research front. Another area of deemed support was maintaining continuity of care for non-COVID patients using virtual consultation services (77.4%), tele-consultation being the preferred option (60%). 58.2% felt that the Government had not involved the private sector adequately; and 45.1% felt they should be part of policy-making. Conclusion: A streamlined pathway to facilitate the private sector to join hands with the public sector for a national cause is the need of the hour. Through our study, we have identified gaps in the current contribution by the private sector and identified areas in which they could contribute, by their own admission.


Subject(s)
COVID-19 , Pandemics , Cross-Sectional Studies , Humans , India/epidemiology , Pandemics/prevention & control , Private Sector , SARS-CoV-2
8.
J Korean Med Sci ; 35(43): e388, 2020 Nov 09.
Article in English | MEDLINE | ID: covidwho-918114

ABSTRACT

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic caused disruptions to healthcare systems and endangered the control and prevention of tuberculosis (TB). We investigated the nationwide effects of COVID-19 on the national Public-Private Mix (PPM) TB control project in Korea, using monitoring indicators from the Korean PPM monitoring database. METHODS: The Korean PPM monitoring database includes data from patients registered at PPM hospitals throughout the country. Data of six monitoring indicators for active TB cases updated between July 2019 and June 2020 were collected. The data of each cohort throughout the country and in Daegu-Gyeongbuk, Seoul Metropolitan Area, and Jeonnam-Jeonbuk were collated to provide nationwide data. The data were compared using the χ² test for trend to evaluate quarterly trends of each monitoring indicator at the national level and in the prespecified regions. RESULTS: Test coverages of sputum smear (P = 0.622) and culture (P = 0.815), drug susceptibility test (P = 0.750), and adherence rate to initial standard treatment (P = 0.901) at the national level were not significantly different during the study period. The rate of loss to follow-up among TB cases at the national level was not significantly different (P = 0.088); however, the treatment success rate among the smear-positive drug-susceptible pulmonary TB cohort at the national level significantly decreased, from 90.6% to 84.1% (P < 0.001). Treatment success rate in the Seoul metropolitan area also significantly decreased during the study period, from 89.4% to 84.5% (P = 0.006). CONCLUSION: Our study showed that initial TB management during the COVID-19 pandemic was properly administered under the PPM project in Korea. However, our study cannot confirm or conclude a decreased treatment success rate after the COVID-19 pandemic due to limited data.


Subject(s)
Coronavirus Infections/pathology , Pneumonia, Viral/pathology , Tuberculosis/prevention & control , Antitubercular Agents/therapeutic use , Betacoronavirus/isolation & purification , COVID-19 , Coronavirus Infections/epidemiology , Databases, Factual , Delivery of Health Care , Drug Resistance, Microbial , Humans , Pandemics , Patient Compliance , Pneumonia, Viral/epidemiology , Republic of Korea/epidemiology , SARS-CoV-2 , Sputum/microbiology , Tuberculosis/diagnosis , Tuberculosis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL